sulfasalazine has been researched along with Hepatitis C in 1 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Hepatitis C: INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mitoro, A | 1 |
Yoshikawa, M | 1 |
Yamamoto, K | 1 |
Mimura, M | 1 |
Yoshikawa, Y | 1 |
Shiroi, A | 1 |
Mochi, T | 1 |
Sakamoto, T | 1 |
Yamao, J | 1 |
Kikuchi, E | 1 |
1 other study available for sulfasalazine and Hepatitis C
Article | Year |
---|---|
Exacerbation of ulcerative colitis during alpha-interferon therapy for chronic hepatitis C.
Topics: Adult; Autoimmune Diseases; Chronic Disease; Colitis, Ulcerative; Hepatitis C; Humans; Interferon Ty | 1993 |